Strategies used by human immunodeficiency virus that allow persistent viral replication (Q33680601)

28 July 2017

1 reference

title

Strategies used by human immunodeficiency virus that allow persistent viral replication (English)

1 reference

28 July 2017

Desrosiers RC

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

5

1 reference

28 July 2017

issue

7

1 reference

28 July 2017

page(s)

723-725

1 reference

Viral dynamics in human immunodeficiency virus type 1 infection

28 July 2017

cites work

1 reference

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

21 January 2018

1 reference

Control of viremia in simian immunodeficiency virus infection by CD8 lymphocytes

21 January 2018

1 reference

Latent infection of CD4 T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

Genetic variation in AIDS viruses

21 January 2018

1 reference

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

21 January 2018

1 reference

Vigorous HIV-1-Specific CD4 T Cell Responses Associated with Control of Viremia

21 January 2018

1 reference

HIV-1-specific CD4 T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

21 January 2018

1 reference

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

21 January 2018

1 reference

A vaccine for HIV type 1: The antibody perspective

21 January 2018

1 reference

Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis

21 January 2018

1 reference

Core structure of gp41 from the HIV envelope glycoprotein

21 January 2018

1 reference

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

21 January 2018

1 reference

Atomic structure of the ectodomain from HIV-1 gp41

21 January 2018

1 reference

The antigenic structure of the HIV gp120 envelope glycoprotein

21 January 2018

1 reference

A role for carbohydrates in immune evasion in AIDS.

21 January 2018

1 reference

Viral Strategies of Immune Evasion

21 January 2018

1 reference

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8 T lymphocytes

21 January 2018

1 reference

Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation

21 January 2018

1 reference

Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein

21 January 2018

1 reference

HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes

21 January 2018

1 reference

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

21 January 2018

1 reference

Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals

21 January 2018

1 reference

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

21 January 2018

1 reference

7 January 2021

Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys

1 reference

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

7 January 2021

Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition

1 reference

7 January 2021

Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1

1 reference

7 January 2021

Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1

1 reference

7 January 2021

Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex

1 reference

7 January 2021

Neutralization of Human Immunodeficiency Virus Type 1 by Antibody to gp120 Is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity

1 reference

7 January 2021

Fusion-competent vaccines: broad neutralization of primary isolates of HIV

1 reference

7 January 2021

Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance

1 reference

7 January 2021

An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens

1 reference

7 January 2021

Identifiers

DOI

10.1038/10439

1 reference

28 July 2017

1 reference